Pumping the brakes on dangerous proteins
November 8, 2024
RNA in the human genome’s understudied ‘Wild West’ might be key to regulating genetic disorders like epilepsy, autism
RNA in the human genome’s understudied ‘Wild West’ might be key to regulating genetic disorders like epilepsy, autism
IRVINE, Calif., Nov. 7, 2024 /PRNewswire/ — Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the U.S. Food & Drug Administration (FDA) approval of the VARIPULSE™ Platform for the treatment of drug refractory paroxysmal Atrial Fibrillation (AFib).
Corin announced that it received FDA 510(k) clearance for its Icona femoral stem implant for total hip arthroplasty (THA).
The drug-device combination developed by MIT spinout Lumicell is poised to reduce repeat surgeries and ensure more complete tumor removal.
Device delivers various sensations, including vibrations, pressure and twisting
BOSTON, Nov. 6, 2024 /PRNewswire/ — Zeta Surgical announced today that its Zeta Navigation System has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for use with expanded instruments and enhanced hospital connectivity.
SimBioSys announced that it received its second FDA 510(k) clearance for TumorSight Viz to expand its use by breast surgeons in the U.S.
Medtronic and Recor Medical each announced separate Medicare reimbursement approvals for their respective renal denervation (RDN) technologies.
Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE).
NeurAxis (NYSE:NRXS) announced today that the FDA granted an expanded 510(k) clearance for its IB-Stim non-implanted nerve stimulator.